P
Profusa
Biotech & Life Sciences · San Francisco, United States · Founded 2009
Medical devices company creating tissue-integrated sensors for chronic disease management and healthy living MoreLess
Profusa is a biotechnology company specializing in the development of biosensors that provide continuous, real-time monitoring of tissue oxygen levels. The company serves healthcare providers and researchers by offering advanced microsensing technology that can detect early signs of diseases such as chronic limb-threatening ischemia and influenza. Operating in the medical technology market, Profusa's business model focuses on the commercialization of its Oxygen Platform and glucose biosensors. The company generates revenue through the sale of these devices and related software solutions. Profusa's technology is particularly valuable for critical care management and remote patient monitoring, making it a key player in the telehealth and medical diagnostics sectors.
Keywords: biosensors, tissue oxygen, real-time monitoring, chronic ischemia, influenza detection, healthcare, telehealth, remote monitoring, medical diagnostics, biotechnology.
Company overview
Profusa company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- San Francisco, United States
- Employees
- 56
- Open positions
- None listed
- Dealroom signal
- 78.4
Valuation & funding
Profusa funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBTDebt | Jul 2025 | $100M | — | Ascent Partners Fund | ↗ |
| SPAC IPOOther financing | Nov 2022 | $0 | — | NorthView Acquisition Corp | ↗ |
| CONVERTIBLEOther financing | Mar 2021 | $0 | — | Sand Hill Angels · Wealthing VC Club | — |
| FundingOther financing | Sep 2020 | $0 | — | Undisclosed | — |
| SERIES COther financing | Aug 2018 | $45M | $180M | VMS Investment Group · Tasly Pharmaceutical · VMS Group · Atinum Investment | ↗ |
| GRANTOther financing | Jul 2016 | Undisclosed | — | ||
| SERIES BOther financing | Dec 2015 | 3E Bioventures | — | ||
| LATE VCOther financing | Jul 2015 | Asset Management Ventures | — | ||
| EARLY VCOther financing | Sep 2013 | Asset Management Ventures | — | ||
| DEBTDebt | Aug 2012 | Undisclosed | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $100K | 0% | 56 |
| 2025 | $100K | 0% | 54 |
| 2024 | $100K | +122.2% | 54 |
| 2023 | $45K | — | 56 |
| 2022 | — | — | 72 |
| 2021 | — | — | 75 |
| 2020 | — | — | 91 |
Growth signals
Profusa website traffic
Latest recorded traffic for Profusa is 3K monthly website visits, up 7.1% over the last three months. Profusa's team grew 3.7% over the past year.
Comparisons
Profusa compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Profusa's talent
Source: Dealroom Talent Intelligence.
Investors
11 investors on Profusa's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Profusa has talent and traffic
team presence
In the news
Latest news about Profusa
Recent press, funding announcements, and product moves mentioning Profusa — open to read from the original sources.
Market sentiment
What the market is saying about Profusa
An AI-synthesized read of the highest-engagement posts about Profusa on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Profusa’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.